Ashok C. Khandkar

President & CEO at Elute

A member of the Company’s Board of Directors since December 2011, Dr. Khandkar was the founding CEO of Amedica (AMDA), an SLC-based spine implant company, from 2000 to 2009. He led Amedica, to an IPO with a prospective valuation of $175M with Morgan Stanley as the lead underwriter, at a 7X step up from Series A financing. In 2010, Dr. Khandkar founded BloXR, a radiation protection company that was sold to an industry buyer in 2014. Prior to that, he held various positions at Ceramatec, Inc. where he started its fuel cell division, ultimately acquired by Rolls Royce PLC. He has over 27 years of experience in leadership positions with responsibility for finance and business development. He is an Adjunct Associate Professor at the University of Utah. Dr. Khandkar earned his Ph.D. in Materials Science from Arizona State University.


Org chart


Teams


Offices

This person is not in any offices


Elute

Elute aims to be the leader in developing and commercializing a new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections.


Industries

Employees

1-10

Links